High-performance liquid chromatographic analysis: Applications to nutraceutical content and urinary disposition of oxyresveratrol in rats

Biomedical Chromatography

Volumn 24, Issue 5, 2010, Pages 516-521

  Bertram, Rebecca M ^a   Takemoto, Jody K ^a   Remsberg, Connie M ^a   Vega Villa, Karina R ^a   Sablani, Shyam ^a   Davies, Neal M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

HPLC; Nutraceutical; Oxyresveratrol; Pharmacokinetics; Stilbene

Indexed keywords

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHODS; LIMITS OF QUANTITATIONS; MOBILE PHASIS; NUTRACEUTICALS; OXYRESVERATROL; PERFORMANCE; STILBENE; ULTRA VIOLET DETECTION; ULTRAVIOLET DETECTION;

PHARMACOKINETICS;

ACETONITRILE; DAIDZEIN; FORMIC ACID; OXYRESVERATROL DIHYDRATE; RESVERATROL; STILBENE; UNCLASSIFIED DRUG; WATER;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DISPOSITION; DRUG STRUCTURE; FLOW RATE; NONHUMAN; NUTRIENT CONCENTRATION; QUANTITATIVE ANALYSIS; RADIATION DETECTION; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION; URINE;

RATTUS;

EID: 77951712578     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1320     Document Type: Article

References (31)

1. Andrabi SA, Spina MG, Lorenz P, Ebmeyer U, Wolf G and Horn TF. Oxyresveratrol (trans-2,3′,4,5′-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia. Brain Research 1017 2004; 1017: 98-107. (Pubitemid 38917149)
2. Ban JY, Cho SO, Choi SH, Ju HS, Kim JY, Bae K, Song KS and Seong YH. Neuroprotective eff ect of Smilacis chinae rhizome on NMDA-induced neurotoxicity in vitro and focal cerebral ischemia in vivo. Journal of Pharmacological Science 106 2008; 106: 68-77. (Pubitemid 351159070)
3. Breuer C, Wolf G, Andrabi SA, Lorenz P and Horn TF. Blood-brain barrier permeability to the neuroprotectant oxyresveratrol. Neuroscience Letters 393 2006; 393: 113-118. (Pubitemid 41821090)
4. Chuanasa T, Phromjai J, Lipipun V, Likhitwitayawuid K, Suzuki M, Pramyothin P, Hattori M and Shiraki K. Anti-herpes simplex virus (HSV-1) activity of oxyresveratrol derived from Thai medicinal plant: mechanism of action and therapeutic effi cacy on cutaneous HSV-1 infection in mice. Antiviral Research 2008; 80: 62-70.
5. Chung KO, Kim BY, Lee MH, Kim YR, Chung HY, Park JH and Moon JO. Invitro and in-vivo anti-infl ammatory eff ect of oxyresveratrol from Morus alba L. Journal of Pharmacy and Pharmacology 2003; 55: 1695-1700.
6. Fang SC, Hsu CL and Yen GC. Anti-infl ammatory eff ects of phenolic compounds isolated from the fruits of Artocarpus heterophyllus. Journal of Agriculture and Food Chemistry 2008; 56: 4463-4468.
7. Huang H, Zhang J, Chen G, Lu Z, Wang X, Sha N, Shao B, Li P and Guo DA. High performance liquid chromatographic method for the determination and pharmacokinetic studies of oxyresveratrol and resveratrol in rat plasma after oral administration of Smilax china extract. Biomedical Chromatography 2008; 22: 421-427. (Pubitemid 351577707)
8. Huang KS, Wang YH, Li RL and Lin M. Five new stilbene dimers from the lianas of Gnetum hainanense. Journal of Natural Products 2000; 63: 86-89. (Pubitemid 30078775)
9. Kanchanapoom T, Suga K, Kasai R, Yamasaki K, Kamel MS and Mohamed MH. Stilbene and 2-arylbenzofuran glucosides from the rhizomes of Schoenocaulon offi cinale. Chemical and Pharmaceutical Bulletin (Tokyo) 2002; 50: 863-865. (Pubitemid 41694914)
10. Kim YM, Yun J, Lee CK, Lee H, Min KR and Kim Y. Oxyresveratrol and hydroxystilbene compounds. Inhibitory eff ect on tyrosinase and mechanism of action. Journal of Biological Chemistry 2002; 277: 16340-16344. (Pubitemid 34967923)
11. Likhitwitayawuid K, Sritularak B, Benchanak K, Lipipun V, Mathew J and Schinazi RF. Phenolics with antiviral activity from Millettia erythrocalyx and Artocarpus lakoocha. Natural Product Research 2005; 19: 177-182. (Pubitemid 40185886)
12. Likhitwitayawuid K, Sornsute A, Sritularak B and Ploypradith P. Chemical transformations of oxyresveratrol (trans-2,4,3′,5′- tetrahydroxystilbene) into a potent tyrosinase inhibitor and a strong cytotoxic agent. Bioorganic and Medicinal Chemistry Letters 2006; 16: 5650-5653. (Pubitemid 44415439)
13. Lorenz P, Roychowdhury S, Engelmann M, Wolf G and Horn TF. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: eff ect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide 2003; 9: 64-76. (Pubitemid 37386375)
14. Maneechai S, Likhitwitayawuid K, Sritularak B, Palanuvej C, Ruangrungsi N and Sirisa-Ard P. Quantitative analysis of oxyresveratrol content in Artocarpus lakoocha and 'Puag-Haad'. Medical Principles and Practice 2009; 18: 223-227.
15. Mouihate A, Horn TF and Pittman QJ. Oxyresveratrol dampens neuroimmune responses in vivo: a selective eff ect on TNF-alpha. American Journal of Physiological Regulation: Integrated Compounds in Physiology 2006; 291: R1215-1221.
16. Oh H, Ko EK, Jun JY, Oh MH, Park SU, Kang KH, Lee HS and Kim YC. Hepatoprotective and free radical scavenging activities of prenylfl avonoids, coumarin, and stilbene from Morus alba. Planta Medica 2002; 68: 932-934. (Pubitemid 35239287)
17. Qiu F, Komatsu K, Saito K, Kawasaki K, Yao X and Kano Y. Pharmacological properties of traditional medicines. XXII. Pharmacokinetic study of mulberroside A and its metabolites in rat. Biology and Pharmacy Bulletin 1996; 19: 1463-1467. (Pubitemid 26403253)
18. Remsberg CM, Yanez JA, Roupe KA and Davies NM. High-performance liquid chromatographic analysis of pterostilbene in biological fl uids using fl uorescence detection. Journal of Pharmaceutical and Biomedical Analysis 2007; 43: 250-254.
19. Remsberg CM, Yanez JA, Ohgami Y, Vega-Villa KR, Rimando AM and Davies NM. Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinfl ammatory, antioxidant and analgesic activity. Phytotherapy Research 2008; 22: 169-179. (Pubitemid 351363234)
20. Roupe K, Halls S and Davies NM. Determination of piceatannol in rat serum and liver microsomes: pharmacokinetics and phase I and II biotransformation. Biomedical Chromatography 2004; 18: 486-491. (Pubitemid 39335030)
21. Roupe K, Teng XW, Fu X, Meadows GG and Davies NM. Determination and assay validation of pinosylvin in rat serum: application to drug metabolism and pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis 2005a; 38: 148-154. (Pubitemid 40725101)
22. Roupe KA, Helms GL, Halls SC, Yanez JA and Davies NM. Preparative enzymatic synthesis and HPLC analysis of rhapontigenin: applications to metabolism, pharmacokinetics and anti-cancer studies. Journal of Pharmacology and Pharmaceutical Science 2005b; 8: 374-386.
23. Roupe KA, Remsberg CM, Yanez JA and Davies NM. Pharmacometrics of stilbenes: segueing towards the clinic. Current Clinical Pharmacology 2006a; 1: 81-101.
24. Roupe KA, Yanez JA, Teng XW and Davies NM. Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats. Journal of Pharmacy and Pharmacology 2006b; 58: 1443-1450.
25. Shin NH, Ryu SY, Choi EJ, Kang SH, Chang IM, Min KR and Kim Y. Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase. Biochemical and Biophysical Research Communications 1998; 243: 801-803 (Pubitemid 28414161)
26. Su BN, Cuendet M, Hawthorne ME, Kardono LB, Riswan S, Fong HH, Mehta RG, Pezzuto JM and Kinghorn AD. Constituents of the bark and twigs of Artocarpus dadah with cyclooxygenase inhibitory activity. Journal of Natural Products 2002; 65: 163-169. (Pubitemid 34171175)
27. Syah YM, Achmad SA, Ghisalberti EL, Hakim EH, Iman MZ, Makmur L and Mujahiddin D. Andalasin A, a new stilbene dimer from Morus macroura. Fitoterapia 2000; 71: 630-635.
28. Takasugi M, Munoz L, Masamune T, Shirata A and Takahashi K. Stilbene phytoalexins from diseased mulberry. Chemistry Letters 1978; 11: 1241-1242.
29. Tsuruga T, Chun YT, Ebizuka Y and Sankawa U. Biologically active constituents of Melaleuca leucadendron: inhibitors of induced histamine release from rat mast cells. Chemical and Pharmaceutical Bulletin (Tokyo) 1991; 39: 3276-3278.
30. Wang TT, Hudson TS, Wang TC, Remsberg CM, Davies NM, Takahashi Y, Kim YS, Seifried H, Vinyard BT, Perkins SN and Hursting SD. Diff erential eff ects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis 2008; 29: 2001-2010.
31. Yang C, Tsai S, Chao P, Yen H, Chein T and Hsu S. Determination of hesperetin and its conjugate metabolites in serum and urine. Journal of Food and Drug Analysis 2002; 10: 143-148. (Pubitemid 35355989)